Han Xie

1.2k total citations
21 papers, 785 citations indexed

About

Han Xie is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Han Xie has authored 21 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Han Xie's work include Cancer, Hypoxia, and Metabolism (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Nausea and vomiting management (2 papers). Han Xie is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Nausea and vomiting management (2 papers). Han Xie collaborates with scholars based in China, Macao and United States. Han Xie's co-authors include Pankaj Seth, Vikas P. Sukhatme, Sabina Signoretti, Vladimir Valera, Angela Amato, Maria J. Merino, W. Marston Linehan, Kerri Burgess, Lev M. Kats and Kevin J. Duffy and has published in prestigious journals such as Nucleic Acids Research, Cell Metabolism and Cancer Research.

In The Last Decade

Han Xie

17 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han Xie China 7 487 444 150 130 92 21 785
Qiang Tan China 21 719 1.5× 397 0.9× 127 0.8× 185 1.4× 80 0.9× 48 1.1k
Yidan Ren China 14 622 1.3× 307 0.7× 252 1.7× 108 0.8× 121 1.3× 23 1.0k
Yi-Chieh Yang Taiwan 15 650 1.3× 325 0.7× 165 1.1× 68 0.5× 108 1.2× 19 869
Shanshan Deng United States 14 452 0.9× 249 0.6× 216 1.4× 85 0.7× 86 0.9× 33 918
Aline Hébrant Belgium 14 496 1.0× 286 0.6× 241 1.6× 54 0.4× 96 1.0× 24 895
Linhua Lan China 17 502 1.0× 205 0.5× 128 0.9× 103 0.8× 103 1.1× 39 749
Feiyu Chen China 20 731 1.5× 493 1.1× 163 1.1× 112 0.9× 85 0.9× 37 1.1k
Roberta Palorini Italy 15 605 1.2× 322 0.7× 154 1.0× 106 0.8× 47 0.5× 23 910
Zhongxue Fu China 20 721 1.5× 319 0.7× 266 1.8× 133 1.0× 180 2.0× 42 1.0k

Countries citing papers authored by Han Xie

Since Specialization
Citations

This map shows the geographic impact of Han Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Xie more than expected).

Fields of papers citing papers by Han Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Xie. The network helps show where Han Xie may publish in the future.

Co-authorship network of co-authors of Han Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Han Xie. A scholar is included among the top collaborators of Han Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Xie. Han Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wenying, et al.. (2025). Bisphenol F (BPF) exposure impairs sperm quality and offspring development in male zebrafish. Toxicology and Applied Pharmacology. 496. 117245–117245. 2 indexed citations
2.
Wang, Yunlong, Mengting Wang, Hong Liu, et al.. (2025). Cation-free siRNA micelle knockdown of EPHA2 improves sensitivity of imatinib for osteosarcoma treatment. Chemical Engineering Journal. 513. 162705–162705.
3.
4.
5.
Xie, Han, et al.. (2024). Ecotoxicological risk assessment of the novel psychoactive substance Esketamine: Emphasis on fish skeletal, behavioral, and vascular development. Journal of Hazardous Materials. 480. 135823–135823. 6 indexed citations
6.
Xie, Han, Li Li, Tao Zhu, et al.. (2024). Genome-integrated Human Papilloma Viruses Testing: A Complement to Colposcopy-guided Biopsy for Cervical Cancer Screening. Current Medical Science. 44(6). 1303–1311.
7.
8.
Xie, Han, et al.. (2023). Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis. Frontiers in Pharmacology. 14. 1268793–1268793. 1 indexed citations
9.
Xie, Han, et al.. (2022). The cost-effectiveness analysis of analgesic treatment options for postoperative pain following laparotomy surgeries. International Journal of Clinical Pharmacy. 45(2). 355–363. 3 indexed citations
10.
Wu, Qibiao, Xingxing Huang, Qianru Zhu, et al.. (2022). A Novel Diagnostic and Therapeutic Strategy for Cancer Patients by Integrating Chinese Medicine Syndrome Differentiation and Precision Medicine. Chinese Journal of Integrative Medicine. 28(10). 867–871. 11 indexed citations
11.
Xie, Han, et al.. (2022). Predictive Factors for Acute Postoperative Pain After Open Radical Gastrectomy for Gastric Cancer. Frontiers in Public Health. 10. 907222–907222. 5 indexed citations
12.
Xie, Han, Jianhua Zou, Qianru Zhu, et al.. (2022). The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–19. 7 indexed citations
13.
14.
Sun, Xueni, Yintao Zhang, Ying Zhou, et al.. (2021). NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1). D1324–D1333. 31 indexed citations
15.
Cheng, Haibo, Weixing Shen, Elaine Lai‐Han Leung, et al.. (2021). Compound Taxus chinensis Capsule Combined with Chemotherapy for Non-Small-Cell Lung Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 4 indexed citations
16.
Chen, Yuanbin, Han Xie, Lei Wu, et al.. (2019). Is Chinese Medicine Injection Applicable for Treating Acute Lung Injury and Acute Respiratory Distress Syndrome? A Systematic Review and Meta-analysis of Randomized Controlled Trials. Chinese Journal of Integrative Medicine. 26(11). 857–866. 13 indexed citations
17.
18.
Seth, Pankaj, Eva Csizmadia, Andreas Hedblom, et al.. (2017). Deletion of Lactate Dehydrogenase-A in Myeloid Cells Triggers Antitumor Immunity. Cancer Research. 77(13). 3632–3643. 117 indexed citations
19.
Xie, Han, Jun‐ichi Hanai, Jian-Guo Ren, et al.. (2014). Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells. Cell Metabolism. 19(5). 795–809. 374 indexed citations
20.
Xie, Han, Vladimir Valera, Maria J. Merino, et al.. (2009). LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Molecular Cancer Therapeutics. 8(3). 626–635. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiang Tan Breakdown of academic impact, for papers by Yidan Ren Breakdown of academic impact, for papers by Yi-Chieh Yang Breakdown of academic impact, for papers by Shanshan Deng Breakdown of academic impact, for papers by Aline Hébrant Breakdown of academic impact, for papers by Linhua Lan Breakdown of academic impact, for papers by Feiyu Chen Breakdown of academic impact, for papers by Roberta Palorini Breakdown of academic impact, for papers by Zhongxue Fu
Rankless by CCL
2026